Actelion regularly updates its investors on the growth opportunity of its innovative pipeline. Corporate events include the Annual General Meeting to update its shareholders, Media & Analyst Day when the full year results are presented, Research and Development Day when Actelion offers updates on its research capabilities and development pipeline, and periodic investor roadshows.
|5 Apr 2017||AGM 2017||The Annual General Meeting 2017 of Shareholders to approve the Business Report|
|20 Apr 2017||Q1 Results 2017||Financial results for the first three months of 2017|
|20 Jul 2017||HY Results 2017||Webcast with financial results for the half year of 2017|
On 7 July 2016 Actelion will held a conference call/webcast to discuss Actelion’s New Dual orexin receptor antagonist.